COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,584 Articles (22,905 medRxiv, 8,679 bioRxiv)

Most recent first Previous |  Page 1514: Articles 15131-15140  | Next

Regular testing of asymptomatic healthcare workers identifies cost-efficient SARS-CoV-2 preventive measures
SANCHEZ-TALTAVULL, D., Castelo-Szekely, V., Murugan, S., Rollenske, T., Ganal-Vonarburg, S. C., Buchi, I., Keogh, A., Li, H., Salm, L., Spari, D., Yilmaz, B., Zimmermann, J., UVCM-COVID researchers, , Gerfin, M., Roldan, E., Beldi, G.
10.1101/2021.06.01.21258124 — Posted: 2021-06-02
Evaluation of the INDICAID COVID-19 Rapid Antigen Test in symptomatic populations and asymptomatic community testing
Chiu, R., Kojima, N., Mosley, G., Cheng, K. K., Pereira, D., Brobeck, M., Chan, T. L., Zee, J. S.-T., Kittur, H., Chung, T., Tsang, E., Maran, K., Yung, R. W.-H., Leung, A. C.-P., Siu, R., Ng, J., Choi, T. H., Fung, M. W., Parkin, S., Chan, W. S., Lam, H. Y., Lee, K. K., Chao, F. C., Ho, S. K.-K., MArshak, D., Ma, E. S.-K., Klausner, J. D.
10.1101/2021.05.26.21257063 — Posted: 2021-06-02
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Grobben, M., van der Straten, K., Brouwer, P. J. M., Brinkkemper, M., Maisonnasse, P., Dereuddre-Bosquet, N., Burger, J. A., Poniman, M., Oomen, M., Eggink, D., Bijl, T. P. L., van Willigen, H. D. G., Wynberg, E., Verkaik, B. J., Figaroa, O. J. A., de Vries, P. J., Boertien, T. M., Le Grand, R., de Jong, M. D., Prins, M., Chung, A. W., de Bree, G. J., Sanders, R. W., van Gils, M. J.
10.1101/2021.05.26.21256092 — Posted: 2021-06-02
COVID Oximetry @home: evaluation of patient outcomes
Boniface, M., Burns, D., Duckworth, C., Duruiheoma, F., Armitage, H., Ratcliffe, N., Duffy, J., O'Keeffe, C., Inada-Kim, M.
10.1101/2021.05.29.21257899 — Posted: 2021-06-02
COVID-19 vaccine acceptance and its socio-demographic and emotional determinants: a multi-country cross-sectional study
de Figueiredo, A., Simas, C., Larson, H. J.
10.1101/2021.05.30.21258074 — Posted: 2021-06-02
Occupational inequalities in the prevalence of COVID-19: A longitudinal observational study of England, August 2020 to January 2021
Green, M. A., Semple, M. G.
10.1101/2021.06.01.21258140 — Posted: 2021-06-02
Vaccine effectiveness of the BNT162b2 mRNA COVID-19 vaccine against RT-PCR confirmed SARS-CoV-2 infections, hospitalisations and mortality in prioritised risk groups
Emborg, H.-D., Valentiner-Branth, P., Schelde, A. B., Nielsen, K. F., Gram, M. A., Moustsen-Helms, I. R., Chaine, M., Seidelin, U. H., Nielsen, J.
10.1101/2021.05.27.21257583 — Posted: 2021-06-02
COVID-19 patient accounts of illness severity, treatments and lasting symptoms
Thomason, M., Werchan, D., Hendrix, C.
10.1101/2021.05.26.21257743 — Posted: 2021-06-02
Clinical validation of colorimetric RT-LAMP, a fast, highly sensitive and specific COVID-19 molecular diagnostic tool that is robust to detect SARS-CoV-2 variants of concern
Alves, P. A., Oliveira, E. G., Franco-Luiz, A. P. M., Almeida, L. T., Goncalves, A. B., Borges, I. A., Rocha, F. S., Rocha, R. P., Bezerra, M. F., Miranda, P., Capanema, F. D., Martins, H., Weber, G., Teixeira, S. M. R., Wallau, G. L., Monte-Neto, R. L.
10.1101/2021.05.26.21257488 — Posted: 2021-06-02
The Female Predominant Persistent Immune Dysregulation of the Post COVID Syndrome: A Cohort Study
Ganesh, R., Grach, S. L., Bierle, D. M., Salonen, B. R., Collins, N. M., Joshi, A. Y., Boeder, N. D., Anstine, C. V., Mueller, M. R., Wight, E. C., Croghan, I. T., Badley, A. D., Carter, R. E., Hurt, R. T.
10.1101/2021.05.25.21257820 — Posted: 2021-06-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).